Prodways Group (PWG) H1 2024 earnings summary

Executive summary

• Revenue for H1 2024 was €31.1M, down 28% year-over-year, mainly due to changes in revenue recognition (IFRS 15), business disposals, and discontinued activities.

• EBITDA margin improved by 4 points sequentially from H2 2023, reaching 8%, but remains below target levels.

• Net income for H1 2024 was €1.3M, down from €3.5M in H1 2023.

• Positive cash generation from operations was maintained despite restructuring and business disposals.

• Measures included ceasing the small jewelry printer activity, selling the Cristal dental lab, and staff reductions to focus on profitable activities.

Financial highlights

• Revenue: €31.1M (H1 2024) vs. €43.0M (H1 2023), -28% year-over-year, with €6.3M due to IFRS 15 and €4.3M to business disposals.

• EBITDA: €2.5M (8% margin), down from €4.8M (11% margin) in H1 2023.

• Operating income: €1.16M, down from €2.44M in H1 2023.

• Cash from operations reached €2.5M, with €13.2M in cash available at June-end and net debt of €3.8M.

• CapEx was limited to €0.6M for the semester.

Outlook and guidance

• Revenue growth of +1% to +5% on a comparable basis and higher EBITDA margin targeted for 2024, with stronger results expected in H2.

• Cost reduction plan of €4–5M over 2024–2025 is on track, with savings split roughly equally between the two years.

• Headcount reduced by about 100 since end of 2023, expected to improve EBITDA margin by €3M annually.